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Implanting stents is the most efficient and minimally invasive technique for treating
coronary artery diseases, but the risks of stent thrombosis (ST) and in-stent restenosis
(IRS) hamper the healing process. There have been a variety of stents in market but
dominated by ad hoc design motifs. A systematic design method that can enhance
deliverability, safety and efficacy is still in demand. Most existing designs are focused
on patient and biological factors, while the mechanical failures related to stenting
architectures, e.g., inadequate stent expansion, stent fracture, stent malapposition
and foreshortening, are often underestimated. With regard to these issues, the self-
expanding (SE) stents may perform better than balloon-expandable (BE) stents, but the
SE stents are not popular in clinic practice due to poor deliverability, placement accuracy,
and precise match of the stent size and shape to the vessel. This paper addresses
the importance between stent structures and clinic outcomes in the treatment of
coronary artery disease. First, a concurrent topological optimization method will be
developed to systematically find the best material distribution within the design domain.
An extended parametric level set method with shell elements is proposed in the topology
optimization to ensure the accuracy and efficiency of computations. Second, the auxetic
metamaterial with negative Poisson’s ratio is introduced into the self-expanding stents.
Auxetics can enhance mechanical properties of structures, e.g., fracture toughness,
indentation and shear resistance and vibration energy absorption, which will help
resolve the drawbacks due to the mechanical failures. Final, the optimized SE stent is
numerically validated with the commercial software ANSYS and then prototyped using
additive manufacturing techniques. Topological optimization gives a rare opportunity to
exploiting the unique advantages of additive manufacturing. Hence, the topologically
optimized auxetic architectures will provide a new solution for developing novel
stenting structures, especially conductive to self-expanding SE stents. The new design
will overcome the limitations of conventional SE stents associated with mechanical
structures while maintain their valuable features, to help reduce the occurrence of ST
and ISR and benefit the clinic practice in treating coronary heart disease.
Keywords: self-expanding stents, auxetic metamaterials, topology optimization, level set method, additive
manufacturing
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INTRODUCTION
The concept of angioplasty in 1964 (Dotter and Judkins,
1964) had helped the development of the first balloon
coronary angioplasty in 1977 (Gruntzig, 1978). Developments
in percutaneous coronary intervention (PCI) technology led to
the generation of new treatment methods for coronary artery
disease (CAD), namely interventional cardiology (Garg and
Serruys, 2010). In order to decrease the rates of restenosis and
abrupt closure of arteries (Gruntzig et al., 1979; Venkitachalam
et al., 2008), coronary stents were first introduced in PCI after
angioplasty (Sigwart et al., 1987). During the early periods,
successful results in treating abrupt and susceptible vessel closure
showed the effectiveness of coronary stents (Roubin et al., 1992).
However, the high rate of subacute thrombotic coronary artery
occlusion after implantation significantly hampers their further
development and application (Serruys et al., 1991). They were
not widely accepted in clinics until the safety of the coronary
stents was evidenced by two comparison studies (Fischman
et al., 1994; Serruys et al., 1994) between stent implantation and
balloon angioplasty. After that, most PCI procedures adopted
coronary stent implantation. The obvious advantage of stent
implantation is the providing of an effective and continuous
support for clogged arteries with minimal invasion. Despite the
above advances, the risks of stent thrombosis (ST), in-stent
restenosis (ISR), and other complications still exist and impact
their safety evolution (O’Brien and Carroll, 2009).
It is hard to prevent ST and ISR at the same time for
stents at today’s market. The implantation of stents will cause
accumulation of macrophages around stents, which lead to
neointimal proliferation of nearby smooth muscle cells and the
new tissue growth still occurs in response to the injury, finally
result in ISR. This proliferation can be greatly limited by drugs
released from drug-eluting stents (DES) (Stettler et al., 2007;
Stone et al., 2007), but the drugs also prevent the formation
of a new endothelial layer which can effectively inhibit clot
formation when compared to the bare-mental stents (BMS).
In the vascular healing, endothelialization plays an important
role to prevent the formation of thrombus. Hence, the first-
generation of DES has been evidenced to be able to effectively
reduce the ISR incidence by 5–15% at 12 months, compared to
20–30% incidence in BMS (Torrado et al., 2018), but it is reported
to trigger an increased incidence of ST (up to 2%) (Palmerini
et al., 2015) at the later stage after implantation, while the much
cheaper BMS suffer an opposite effect (1.2% in ST) (Torrado
et al., 2018). These issues result in the development of seeking
new polymer coatings, antiproliferative drugs, and materials of
stent platform, such as biodegradable or bioresorbable materials
(McMahon et al., 2018; Siiki et al., 2018). However, several
ABSORB trials of biodegradable stents (BDS) (Kang et al., 2014)
and bioresorbable vascular scaffolds (BVS) demonstrate inferior
outcomes, evidenced by the fact that the first type of commercial
biodegradable stents were withdrew from the market in 2017.
These developments are successfully in control ISR in short-
term, especially for the second-generation DES with less than 5%
incidence within 12 months, the high-profile BDS and BVS are
recently still limited by their materials and present a slight higher
ST incidence, 0.5–1.3% and 1.4%, respectively, compared with
0.7% in the second-generation DES (Kalra et al., 2017). Although
the second generation DES are superior to other current stents
and recommended in the clinic use, the long heal time are still
facing late stent failure that may result in an increased occurrence
of ISR and ST (Torrado et al., 2018). ST is a complex multifactor
pathophysiology, and it is a rare complication but with high
mortality (5–45%), relapse rate (15–20%) at 5 years (Gori et al.,
2019). ISR is also a concerned issue when facing long-term
treatments. Hence, the risk of stent thrombosis and restenosis still
demands new development of stents.
Apart from patient and biological reasons, the mechanical or
procedural factors also play in important role in the incidence
of ST and ISR, e.g., inadequate stent expansion, stent fracture,
late stent malapposition and foreshortening. These issues due to
stenting structural and procedural issues occur no matter what
kind of stents are employed. Neointimal hyperplasia will occur
once the gap exists between the struts and the vessel wall, which
may lead to a risk of ISR (Foin et al., 2014). There has been
evidence that these mechanical factors were associated with late
or very late ST (Gori et al., 2019). Based on the mechanism
of stenting expansion, stent struts can be divided into self-
expanding (SE) and balloon-expandable (BE). With respect to the
above issues relevant to mechanical structures, SE stents show
certain superiority than BE stents.
SE stents are often constrained within a delivery catheter
until positioned and deployed. It expands spontaneously when
released from the constraining device, and several different
mechanisms can be used to achieve “self-expanding,” such as
shape memory property of materials and mechanical “spring-
like” design to achieve expansion. After implantation with a
full deployment, they position themselves against the vessel
wall with a slowly released but continuously supported outward
force. They are normally characterized with a less hoop strength
that can be defined as the resistive force to radial compressive
forces, in comparison with BE stents. SE stents are usually
made of superelastic materials, such as Nitinol, an alloy of
nickel and titanium with excellent corrosion resistance and
biocompatibility, and nitinol SE stents are manufactured to have
a size slightly larger than the target vessel size.
Although SE stents are not as popular as BE stents in
application, it has a strong ability in some atypical and complex
coronary anatomy (Lu et al., 2018; Pellegrini and Cortese, 2019),
demonstrated by the successful clinic use of commercial product
Stentys R© Self-Apposing R© stent. The benefits of SE stents can
be summarized as follow: (1) the gradual expansion process of
SE stents results in no-reflow and a lower incidence of edge
dissections, as well as avoidance of inadequate stent expansion
(Kidawa et al., 2017); (2) the avoidance of immediate vessel
wall injury, leading to a lower injury response of the artery,
so as to reduce the incidence of acute thrombosis, as well as
neointimal hyperplasia for ISR and a larger lumen area (Schmidt
and Abbott, 2018); (3) continuously supplying radial outward
force to support vessel wall to prevent the occurrence of late
stent malapposition and the complications (Kidawa et al., 2017;
Lu et al., 2018). Hence, SE stents can effectively support the
enlarged vessel after the disruption of plaques; and (4) the
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supply of better flexible deformation, especially for bifurcations
and vessels with a significant tapering (Pellegrini and Cortese,
2019) due to material elasticity rather than the permanent
deformation of plasticity from BE stents, leading to a low
fracture incidence. More introduction for self-expanding stents
may refer to https://www.sciencedirect.com/topics/nursing-and-
health-professions/self-expanding-stent.
However, the current development and application of SE
stents are significantly hindered by some drawbacks. The first is
the relatively large profile of the catheter that makes the delivery
system cumbersome, which increases the difficulty of delivering
and the risk of injury during percutaneous puncture. The second
is a complicated procedure caused by the phenomenon of stent
foreshortening that lows the deployment accuracy (Schmidt and
Abbott, 2018). When expands, the superelasticity of SE stents
often comes with the cost of a foreshortening such as 20% of
the undeployed length, which makes positioning difficult. The
deviation of deployment can lead to uncovered lesions, resulting
in a high risk of thrombosis complications. The third is the
precise requirement of matching the stent shape to the target
vessel shape. In practice, the diameter of a SE stent can hardly
be precisely evaluated due to the complexity of real-world clinic
cases, as an over-small size may cause stent malapposition, and
an over-large size may lead to a larger lumen even a negative late
loss of stent (Schmidt and Abbott, 2018). Stent malapposition,
or incomplete stent apposition, is a morphological description
used to indicate one or more stent struts that do not contact
the intimal surface of vessel wall tightly. Stent malapposition is
of great importance, as it may increase the risk of subsequent
stent thrombosis.
With respect to most up-to-date stents (both SE and BE
stents), the importance between stenting structural designs
and their clinic outcomes in the treatment of coronary artery
disease has been underestimated. Furthermore, the current
designs for seeking new generations of stents are more focused
on the improvement of stent performance based on material
properties and biological aspects. However, a stent performance
depends on not only the new materials and biological factors
but also stenting structural architectures. The stents are first-
of-all both a mechanical and biological structure to expand
clogged arteries with appropriate elasticity and flexibility, while
simultaneously withstand the radial compressive forces with a
prescribed hoop strength.
Since finite element method (FEA) provides an efficient
computational tool to evaluate mechanical properties of stents
(Karanasiou et al., 2017; Chen et al., 2020), more and more studies
began to focus on the design of stent with FEA (Bressloff et al.,
2016; Blair et al., 2019). For instance, surrogate modeling (Putra
et al., 2019) is widely used to perform size or shape optimizations
for stent structs. The objective function include dogboning (Chen
et al., 2019), foreshortening (Torki et al., 2020), flexibility (Shen
et al., 2019), radial stiffness (Torki et al., 2020), recoil (Li et al.,
2016), fatigue strength (Alaimo et al., 2017), and haemodynamic
disturbance (Prithipaul et al., 2018; Putra et al., 2019). The design
parameters are usually the thickness, link width and length,
strut width and length, curve radius, profile shape, and pattern
numbers. However, no matter what kind of surrogate models are
used, size optimization gives a narrow space to improve stent
performance, as the design only depends on size parameters
under a given shape and topology.
In this paper, we will develop a more effective systematic
design method to find new stenting structures for future
generation of SE stents, with a view to improving stent
performance by optimizing stenting structure of topology and
shape. The new designs for stenting structural architectures
will eventually improve stent safety to low the incidence of
restenosis and thrombosis. Hence, to help overcome the above
drawbacks in current SE stents, this paper will firstly introduce
the auxetic microstructures (Lakes, 1993; Evans and Alderson,
2000) into SE stents to achieve closed-cell stents, and then
develop an enhanced topological optimization method with
level sets (Luo et al., 2007; Li et al., 2016), which is more
accurate and more efficient in finding the best architecture for
auxetic microstructures.
Auxetics are a family of mechanical metamaterials, with
microstructures artificially engineered to have unusual elasticity
property, namely, negative Poisson’s ratio (NPR). Auxetics
contract in transverse direction when compressed in axial
direction and vice versa. Auxetics provide potential for a wide
range of applications in different fields, due to their unique
properties for energy absorption, anti-impact, indentation
resistance, thermal isolation, and fracture toughness. Auxetics
will particularly benefit the SE stents from the following aspects:
(1) Auxetic behavior can help make the size of SE stents much
smaller than current profile of SE stents. Small profiles of SE
stent systems will facilitate deliverability, and therefore reduce the
occurrence of complications due to potential injury in the process
of percutaneous coronary intervention. After implantation, they
fully stretched themselves and adaptively fit the vessel wall. This
will help reduce the potential injury to arterial intimal surface,
leading to a low injury response and therefore restenosis.
(2) The effective NPR property of auxetic microstructures
makes SE stents have non-shortening that facilitates accurate
sent deployment when deployed, which further reduces stent
malapposition. As we know, stent implantation often leads to
suboptimal results, e.g., the occurrence of strut malapposition,
especially in cases of complex lesions and other factors.
The indentation resistance of auxetics enables a superior
conformability of stent struts to automatically match the vessel
wall surface, allowing the stent to contact the vessel surface
perfectly without foreshortening and malapposition.
(3) The auxetic microstructures can adaptively respond to
different radial compressive force, thus make the auxetic stent
have variable hoop strengths that allows the stent to easily adapt
complex shapes in interventional cardiology such as tortuous
and clogged arteries. Coronary stent size matters. In response
to large artery size and small radial force, the auxetic stent
will automatically change its shape, and it will continuously
expand outwardly and reduce its radial resistance force, to avoid
malapposition. Otherwise, when the auxetic stent subject to a
small artery size and large hooping force, the stent will increase
its structural stiffness and strength (due to indentation resistance)
to withstand an increased radial compressive force applied to
the stent from the vessel. The adaptive stiffness and strength
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provided by the auxetic stents will help reduce the risk of
restenosis and thrombosis.
(4) The auxetics can also improve stenting mechanical
performance and reduce the happening of stent fracture and
enhance their ability to withstand fatigue and vibration, because
the NPR property can greatly improve the fracture toughness of
structures. This will also benefit a low incidence of restenosis.
Topology optimization has been a popular option to realize
the optimization of shape and topology of geometries, because
it is a numerical procedure that can iteratively find the best
material distribution in the design domain. Few studies have
attempted to introduce topology optimization into the design
of stents, such as (James and Waisman, 2016), but the topology
optimization was only used for a bi-stable design during the
expansion of the stent to eliminate the axial displacement.
There has been no previous work that systematically integrates
topology optimization with auxetics to develop auxetic SE stents,
and no work has employed multiscale concurrent topology
optimization method to create novel stenting structures. Hence,
topology optimization can find the optimized performance of
stenting structures, associated with the best material layout and
the most efficient material usage in the design. Particularly,
the concurrent multiscale topology optimization method, with
X-PLSM and the numerical homogenization method, can
systematically integrate the NPR mechanical metamaterials into
the SE stent to implement a new mechanism for expanding,
by fully making use of the auxetic behavior of microstructures.
The topologically designed, micro-structured, multiscale cellular
composite structure is characterized with small size, large
expansion, uniform radial force and super compliance, helping
avoid the injury to vessel surface, edge-dissection and side-
branch, to low thrombosis and restenosis.
DESIGN METHOD
In this section, the X-PLSM and the numerical homogenization
method is combined as a system to conduct the heuristic
multiscale concurrent topology optimization for design of
auxetic SE stents.
Numerical Homogenization Method
The homogenization (Bendsøe and Kikuchi, 1988; Suzuki and
Kikuchi, 1991) technique assumes that the design domain is
composed of periodic configuration of unit cells, which are much
smaller that the bulk material in size. Based on that concept,
in this paper, the numerical homogenization method will be
used to roughly estimate the effective properties of micro/meso























where i, j, k, l and p, q, r, s are all used to denote 1, 2.  is the
design domain; | | is the area of the design domain; Dpqrs is
the elasticity tensor of the base material; ε0(ij) pq is the test unit
strain field, where (1,0,0)T , (0,1,0)T and (0,0,1)T are used in two-
dimensional cases; ε∗(ij) pq is the locally varying strain field due


















By using the finite element method with periodic boundary















d = 0, ∀ v(kl) ∈ Ū () (3)
where ν(kl) is the virtual displacement field in−U(),
which denotes the space of all the kinematically admissible
displacements in the design domain .
Level Set-Based Parameterization
Method
Topology optimization is used to perform the optimization
of the periodic microstructures. The most popular topological
optimization methods includes the SIMP method (Solid Isotropic
Material with Penalization) (Zhou and Rozvany, 1991; Bendsøe
and Sigmund, 1999), and the Level set method (Sethian and
Wiegmann, 2000; Wang et al., 2003; Allaire et al., 2004). The
level set method adopts an implicit description scheme, to embed
the design boundaries of the structure into the zero level set of a
higher-dimensional level set function, where an illustration of 2D
example is presented in Figure 1.
















where x is the point in the space D.  and ∂ denote the design
domain and the boundary, respectively.
Since the optimization is driven by the evolution of the level
set function, shape and topology of the structure with clear
boundaries can be achieved at the same time. However, most
conventional level set methods require complicated numerical
implementations, e.g., the re-initialization, extension of the
boundary velocity field and CFL condition. To overcome these
limitations, several alternative methods have been developed,
such as the parametric level set method (PLSM) (Luo et al.,
2007, 2009) based on compactly supported radial basis functions
(CSRBFs) has been successfully applied in dealing with designs
in mechanical metamaterials (Wang et al., 2014; Wu et al., 2017;
Li et al., 2018).
In the conventional level set method, the optimization process
is described as the dynamic motion of the level set function
8(x). By introducing a pseudo time t, this dynamic change can
be determined using Eq. (5), which is actually the Hamilton–
Jacobi partial differential equation (PDE). Thus, the optimization
is transferred into a procedure to find an appropriate velocity field
vn to solve the Hamilton–Jacobi PDE.
∂8 (x, t)
∂t
− vn |∇8(x, t)| = 0 (5)
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FIGURE 1 | (A) 3D level set surface; (B) 2D level set boundary.
Within the PLSM, the level set function is calculated through
centrally positioning CSRBFs at a set of given knots over the
whole design domain. That interpolation method is as follows:
8(x, t) = ϕ (x)T α (t) =
N∑
i=1
ϕ (x) αi (t) (6)
where N is the number of fixed knots in the design domain. The
vector with the CSRBFs functions is:
ϕ (x) = [φ1 (x) , φ2 (x) , ... , φN (x)]T (7)
and the expansion coefficient vector is given by:
α (t) = [α1 (t) , α2 (t) , ... , αN (t)]T (8)
the CSRBFs of the ith knot used with C2 continuity is given as:
φi (x) = max
{
0, (1− ri (x))4
}
(4ri (x)+ 1) (9)
and ri(x) is defined as:








where dI denotes the distance between the current sample knot
(x, y) and the ith knot (xi, yi), and dmI is the influence domain of
the knot (x, y), which means only the knots in that domain can
affect the current CSRBFs function.
Since all the RBF knots are fixed in the design domain, this
interpolation separates the time and space from the level set
function. The original level set function8(x,t) is now determined
by the spatial functions ϕ(x) located at the knots and the temporal
only expansion coefficient α(t). The PDE-based level set model
is transformed into the following ODE (ordinary differential
equation) system:
ϕ (X)T α̇ (t)− vn
∣∣∣(∇ϕ)T α (t)∣∣∣ = 0 (11)
Hence, the normal velocity field are given as:
vn =
ϕ (X)T∣∣(∇ϕ)T α (t)∣∣ α̇ (t) , where α̇ (t) = dα (t)dt (12)
Extended Parametric Level Set Method
Most stenting structures can be regarded as thin-walled
structures. The thickness of most stents is around 100 µm, much
smaller than sizes of width and length that are usually 4 and
10 mm, respectively. Therefore, the shell element is more suitable
for approximating structures of stents. A shear deformable shell
element with four nodes is used in this paper. Each element has
four nodes and each node has three degrees of freedom wi, θxi and
θyi, as shown in (13). This kind of element is more convenient and
accurate to capture deformation of thin-walled stenting structure.
When preforming finite element analysis, the element stiffness
matrix is assembled by two parts as illustrated in (14): bending






, where θxi =
∂wi
∂y
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where, E and G are Young’s modulus and shear modulus,
respectively. µ is Poisson’s ratio. k is the shear energy correction
factor; and h is the thickness of the shell element.
The numerical implementation method based on zero iso-
contour used in the level set method can be utilized to solve a
curved shell model, but it has higher computational cost. The
level set function (4), can also be described as Eq. (15), where












Hence, if the velocity components are transferred in curvilinear
coordinates, the evolution of the level set function can also
be described with curvilinear coordinates. As an illustration in
Figure 2, the blue color shows a level set function, while the
white intersection line is the boundary of a four-node shell
structure, located at the zero-level set which is presented as the
red curved surface.
Initially, this kind of transformation rule was used to deal with
fluid issues (Horiuchi et al., 2004; Yue et al., 2005). Park and Youn
(2008) introduced this transformation into level-set topology
optimization. Based on the above works, the transformation of
the level set function from Cartesian coordinates to curvilinear





















gj · gj (16)
where, J = det[J], and J is the Jacobian matrix; gj is
the covariant basis vector in curvilinear coordinates ξ j([ξ ,
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FIGURE 2 | Level set function in curvilinear coordinates.
η, ζ]), and v j ξ is the velocity component in the ξ j-
coordinate direction.
Then, we propose an extended PLSM (X-PLSM) by applying
this transformation rule into the PLSM based on CSRBFs (Luo
et al., 2007). Since the time-derivative is only related to the
expansion coefficient α(t) in PLSM, the transformation can be
applied only for the spatial functions ϕ(x), as shown in (17),
where the subscript ξ donates parameters in the curvilinear
coordinates ξ j([ξ , η, ζ]), and ϕξ (ξ ) is the transformed
spatial functions.
8ξ (ξ, t) = ϕξ (ξ)T αξ (t) =
N∑
i=1
ϕξ (ξ) αξ,i (t) (17)
Then, the level set model in Eq. (11) can be rewrite in the
curvilinear coordinates, as Eq. (18).
ϕξ (ξ)
T α̇ξ (t)− vnξ
∣∣∣(∇ϕξ )T αξ (t)∣∣∣ = 0 (18)
where, v n ξ is the normal velocity field in the curvilinear
coordinates, and can be given by:
vnξ =
ϕξ (ξ)






In this paper, the objective of the design is to obtain a structure
with both auxetic behavior and the stiffness to support vascular
walls. Therefore, a concurrent topology optimization strategy is
adopted to achieve the design of the auxetic structure in the micro
scale and meet the compliance requirement in the macro scale.
Since the structure of a stent should be composed of periodic unit
cells in a scale that is much bigger than the real microscale, the
concept of multiscale in this paper is a kind of heuristic model.
In this heuristic multiscale model, the auxetic property is still
obtained in a micro scale, but the macrostructure is periodically
composed of auxetic microstructures. The realization and
relevant sensitivity analysis will be discussed in this section.
Optimization Model
Initially, the effective elasticity tensor of the microstructure is
firstly calculated, and then the Poisson’s ratio is evaluated based
on the effective elasticity tensor. Then, the objectives in macro
and micro scales are calculated, respectively. After that, they are
normalized and assembled by weight factors. Meanwhile, the final
sensitivity of multiscale is obtained in the same way. Finally,
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 6 July 2020 | Volume 8 | Article 736
fbioe-08-00736 July 11, 2020 Time: 16:32 # 7
Xue et al. Topological Optimization of Auxetic Stents
X-PLSM is used to update the coefficients of the interpolation
and so the structural shape and topology. In this optimization,
the macrostructures are configured by a series of uniform
microstructures. The overall concurrent topology optimization
using X-PLSM is formulated as:











































































































αM Iξ, min ≤ α
M I




where, the superscript “MA” denotes the parameters in the macro
scale, and “MI” in the micro scale. The subscript ξ denotes the
parameters in the curvilinear coordinates ξ j([ξ , η, ζ]). N is the
total number of fixed knots in the micro design domain. The
expansion coefficients of the CSRBF interpolation αMI ξ , n are
the design variables in the micro scale, ranging between αMI
ξ , min and αMI ξ , max. J is the equivalent objective function,
comprised of the macro compliance JMA and micro Poisson’s
ratio JMI , where W1 and W2 are corresponding weight factors.
V is the volume constraint and the upper limitation is defined as
Vmax ξ . H is the Heaviside function (Wang et al., 2003) used to




















2 −1 ≤ 8
M I
ξ ≤ 1
1 8M Iξ > 1
(21)
where 2 is a small positive number to avoid the singularity of
the element stiffness matrix, and1 is the width for the numerical
approximation ofH. δ is the Dirac function which is the derivative















) ∣∣∣8MIξ ∣∣∣ ≤ 1
0
∣∣∣8MIξ ∣∣∣ > 1
(22)
The elasticity tensor of that shell element is comprised of
Db and Ds shown in (14), and the target Poisson’s ratio is
mainly related to Db. Therefore, the effective elasticity tensor of
the microstructure DH ijkl(DbH ijkl, Ds) is assembled by the
effective elasticity tensor DbH ijkl and the constant Ds. After
that, the global stiffness matrix K in macro design domain can
be calculated by DH ijkl. Here, the optimized microstructure
is defined as isotropic or orthotropic material. Thus, there are
two Poisson’s ratios µ1 and µ2 defined in the micro objective
function, and they can be obtained by DbH 11, DbH 12, DbH 22,

















In the above formulas,8MI ξ is the level set function in the micro
design domainMI ξ . It can be calculated using spatial variables
in the curvilinear coordinates [ξ , η, ζ] and time variables t based
on the CSRBF interpolation in Eq. (24)




· αMIξ, n (t) (24)
The effective elasticity tensor DbH ijkl can be obtained through




































where Db pqrs is the elasticity tensor of the solid material; ε0 pq is
the test unit strain field, (1,0,0)T , (0,1,0)T and (0,0,1)T as for the
2D problem; ε∗ pq is the strain field related to the displacement
uMI ξ , which can be calculated via finite element analysis using



























where w is the virtual displacement field. The bilinear energy
and the linear load forms of the finite element analysis in the






















































The bilinear energy and the linear load forms in the macroscale




































where p is the body force and τ is the traction of the boundary
0MA ξ in the macroscale.
Design Sensitivity Analysis
Based on the above concurrent topology optimization model, the
sensitivity of the objective function can be obtained. Because of
two scales, the sensitivity is divided into two parts and calculated
through the first-order derivatives of the objective functions with
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The effective elasticity tensor DH ijkl is comprised of two parts,
where DbH ijkl is the function of design variables and Ds is















Then this sensitivity is utilized to calculate the first-order
derivatives of DbH ijkl with respect to the design variables. Based
on the shape derivative, the first-order derivatives of DbH ijkl
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The first-order derivatives of DbH ijkl with respect to t can also
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Comparing Eqs (34) and (35), the first-order derivatives of DbH

































FIGURE 3 | The flowchart of the concurrent topology optimization.





∂ (µ1 + 1)2
∂αMIξ
+



















And the derivatives of the volume constraint with respect to the















The flowchart of the proposed optimization method is given
in Figure 3. At first, the micro displacement fields uMI ξ is
obtained by solving the equilibrium equation Eq. (26). Then,
the effective elasticity tensor DbH ijkl can be computed by
using numerical homogenization method in Eq. (25). After that,
the value of the micro objective function JMI in Eq. (20) is
calculated. The sensitivity of JMI and the micro volume constraint
with respect to design variables are obtained in Eqs (37) and
(38), respectively. Simultaneously, the effective DbH ijkl and the
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FIGURE 4 | (A) Macro design domain; (B) micro design domain.
FIGURE 5 | The optimization of 35% volume fraction: (A) Initial design; (B–E) four intermediate results; (F) final design.
FIGURE 6 | (A) The convergent histories of objective and volume; (B) Poisson’s ratios.
constant Ds are utilized to compute the global stiffness matrix K
of the macro structure, and then the macro equilibrium equation
can be solved to get the macro displacement field uMA ξ .
The macrostructural compliance and the derivative of JMA are
then calculated by JMA in Eqs (20) and (31), respectively. Based
on defined weight factors W1 and W2, the value of objective
function J and relevant sensitivity can be determined. After
that, the OC method is adopted to update design variables.
The loop of the optimization is performed until the convergent
criterion is satisfied.
NUMERICAL RESULTS
The concurrent topology optimization is implemented with
MATLAB to obtain the micro-structured cellular composite
structure with auxetic deformation. In the process, a piece of thin-
walled structure is adopted as the macro design domain, which is
indicated in blue color in Figure 4, subject to the loading and
boundary conditions. The displacement of the stent along the
circumference is fixed, while two unit forces are applied on the
left and right edges in the axial direction. Meanwhile, the micro
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FIGURE 7 | The optimization of 25% volume fraction: (A) Initial design; (B–E) four intermediate results; (F) final design.
FIGURE 8 | (A) The convergent histories of objective and volume; (B) Poisson’s ratios.
FIGURE 9 | The optimization of 20% volume fraction: (A) Initial design; (B–E) four intermediate results; (F) final design.
design domain is indicated in red color in Figure 4. Considering
the computational efficiency and accuracy, the macro design
domain is discretized by 30 × 30 shell elements with four nodes,
where each element has a unit length, height. The micro design
domain is discretized by 50× 50 shell elements.
Coronary Stents are tube-shaped devices with close-cell units
to keep the clogged arteries open. To adapt to a range of
different arterial shapes, stents should have enough flexibility to
accommodate turns or angles. Therefore, no matter what kind
of coronary stents, most of them have low volume fractions of
materials. Different volume fractions in the optimization can
lead to different results with different negative Poisson’s ratios.
In this design, 35% volume fraction is adopted at first. Then,
the subsequent designs with smaller volume fractions will be
determined based on the evaluation of the design with 35%









where DbH 11, DbH 12, DbH 22 are specific values within the
effective elasticity tensor.
The Result of 35% Volume
The optimization results with 35% volume fraction are presented
in Figure 5. To track the dynamic change of the structural
boundary during the optimization process, four intermediate
results are used, as shown in Figures 5B–E), while Figures 5A,F
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FIGURE 10 | (A) The convergent histories of objective and volume; (B) Poisson’s ratios.
FIGURE 11 | The final numerical design result.
FIGURE 12 | The geometry of the optimized stent.
are the initial design and final result, respectively. Except normal
fluctuations from 10th to 30th optimization iterations, the
objective function steadily minimized to close zero, and the
convergence curve is shown in Figure 6A). The volume fraction
of the structure is also steadily converged to 35%. These results
indicate the proposed method is robust. The changes of the two
Poisson’s ratios during the process are given in Figure 6B, where
the results are Mu1 = -0.8180, and Mu2 = -0.8120. The two
ratios are nearly “-1” close to the design objective, which shows
that the method can effectively achieve a design with auxetics.
However, the material distribution of the optimized structure
is not uniform. The connections between the center and four
branches are thinner than other parts, which can lead to non-
uniform distribution of radial force. It will easily cause stent
fracture at the thin connections, and result in a high incidence
of ISR and ST. Besides that, the central region of the structure
occupied by more than half materials without any gap, which
may block side branches of arteries. Therefore, a smaller volume
fraction 25% is then used to remove more materials from the
thick branches and the center location.
The Result of 25% Volume
The optimization process of 25% volume fraction is then
presented in Figure 7. And the convergence curves, similar to
the design of 35%, can be found in Figure 8. The results of
two Poisson’s ratios are Mu1 = -0.8209, and Mu2 = -0.8179,
respectively. Compared with the result of 35% volume, in this
case, the materials in the 4 branches and connections are better
evenly distributed. However, the same issues still exist in the
center of the structure, although a small hole is generated.
The Result of 20% Volume
Therefore, 20% volume fraction is then used, aiming to removing
more materials from the center position of the structure. The
design results can be found in Figure 9, while the convergence
curves are shown in Figure 10. The results of two effective
Poisson’s ratios of the microstructure are Mu1 = -0.8180, and
Mu2 = -0.8186.
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FIGURE 13 | (A) Compression test; (B) Stretching test.
FIGURE 14 | Stent expansion test: (A) 3D view; (B) front view.
Hence, based on the comparison of these three designs, it can
be seen all of them have similar negative Poisson’s ratios at the
peripheral and axial directions, and they are all close to the design
objective. Nevertheless, the material distribution in the design of
20% is more uniform than others. It can provide a radial force that
is better distributed to support vessels to prevent non-uniform
expansion. The big hole in the center of the structure increase
the gap of the stent to benefit blood flow from side branches of
the arteries. Although less cover rate of the stent can reduce the
biological rejection, a reasonable amount of materials can provide
stronger and long-last support for the vessel and prevent higher
incidence of complications caused by mechanical failures of the
stent. Therefore, the third numerical design is adopted, as shown
in Figure 11.
VALIDATION
From the numerical results, the topological design of auxetic
stenting structures can overcome the limitations of conventional
SE stents caused by the mechanical structural issues. Auxetic
deformation has shown a great potential in enhancing the
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FIGURE 15 | (A) printed in the printer Stratasys J750; (B) the prototype of the
auxetic stent.
flexibility, conformability, and adaptability of the stent to prevent
immediate injury, inadequate expansion, malapposition, and
foreshortening issues, so as to reduce the incidence of ST and ISR.
The topologically optimized design validations will be validated
through numerical simulations with the commercial software
ANSYS v2019R1.
Simulation in ANSYS
To perform the simulation for the design, the geometry should be
built based on the numerical design result. Firstly, the numerical
design result (Figure 9) in MATLAB is output as a STL type
file. Then, the STL file is imported into the software SpaceClaim
which is integrated into ANSYS, to get the solid geometry for
simulations. As mentioned in the design strategy, the optimized
structure is the result with periodic microstructures, but it is
hard in practice to use microstructures with very small scale by
considering computational cost and manufacturing challenges. It
is reasonable when considering the microstructures are actually
independent of real dimensions but a relative scale. Therefore,
the stenting architecture is assembled with 24 unit cells in the
peripheral direction and 25 unit cells in the axial direction. Due
to the use of the shell element, the geometry is modeled as a
cylindrical surface with a specified thickness, which can help
reduce the computational cost. The geometry of the optimized
stent structure is illustrated in Figure 12. As the commonly used
material in SE stents, Nitinol is utilized for the optimized stenting
architecture in the simulation.
Simulation of NPR Behavior
In that part, the compression and stretching tests are performed
to validate the deformation mechanism of the optimized stenting
architecture. The results are illustrated in Figure 13, where
the gray outline wireframe shows the undeformed stent. With
the compression, the NPR behavior can be easily found, which
shows the size of the optimized stenting architecture becomes
much smaller than undeformed shape in both peripheral and
axial directions, which will benefit deliverability of the stent.
Due to the stored strain energy from the elastic deformation,
the stent structure can recover its undeformed shape via
expansions in all directions when the compressed sent structure
is released. Therefore, this deformation behavior can eliminate
foreshortening when deploying the stent. The NPR behavior
can also be demonstrated in the stretching test. The maximum
equivalent stress in the validation model is 299.76 Mpa, much
smaller than the yield stress of material Nitinol that is usually
greater than 600 Mpa. Hence the new stenting structure has good
strength to withstand circle loading in practice and low the risk
of failure fracture.
Simulation of Inadequate Expansion and
Malapposition
Stents without desired flexibility and conformability may
experience inadequate expansion and malapposition, to further
result in an increased incidence of ST and ISR. Therefore,
the simulation of the stent here is to test these mechanical
performances of the optimized stenting architecture. The
LSDYNA within ANSYS is utilized to simulate the expanding
process for the stent. To reduce the computational cost, only a
part of the stent is illustrated to simulate the expansion of the
stent to the target vessel with a big plaque on the surface, as
shown in Figure 14. From the result, it can be seen the stent
adequately expands to cover the whole lesion, and adaptively
deforms to fit the shape of the vessel with no gaps around the
plaque. As we known, the stent malapposition can be described
as gaps existing between the stent and the vessel wall. Hence, the
current simulation result can demonstrate the optimized stent
structure has excellent flexibility and conformability to prevent
stent inadequate expansion and malapposition. Finally, all these
benefits will help reduce the incidence of ST and ISR.
3D Printing
The additive manufacturing (3D printing) technology is
particularly beneficial to the fabrication of solid geometries with
complex shapes. Topologically optimized microstructures are
often characterized with complex geometries, not compatible
with most conventional manufacturing techniques. Hence it is a
natural choice to implement topological designs with 3D printing
methods. The prototype of the designed stenting architecture was
enlarged by 15 times and then was printed using the Stratasys
J750 machine at the ProtoSpace, the University of Technology
Sydney. This machine can produce ultra-smooth surfaces and
fine features with layer thickness as fine as 0.014 mm, to well
represent the stent structure with auxetic microstructures.
Topologically optimized designs often come with complex
geometric shapes. How to manufacture the designs is also an
important aspect that should be considered. In this work, due
to the cost consideration and demonstration purpose, this paper
employs a kind of plastic material for prototyping validation
of the optimized design, rather than metallic materials, such as
Nitinol. The material for the prototyping is composed of 30%
Vero and 70% Tango, which can approximate the property of
elastomer. The prototype is printed layer by layer following the
axial direction as shown in Figure 15A. To avoid deformation
of the structure during the printing, the prototype is supported
by a solid cylinder filled inside with the same material. After
that, the solid cylinder will be washed. The final prototype
for the demonstration of the new stenting structure with 1.5
mm thickness is shown in Figure 15B. It is noted that any
biocompatible materials can be used for production of the
topologically optimized auxetic stents. In our near future work,
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the testing and characterization of the optimized auxetic SE stents
with Nitinol will be conducted.
CONCLUSION
This paper proposes a topology optimization method for the
design of auxetic SE stents to reduce the risks of ST and
ISR caused by mechanical or procedural factors of SE stents,
such as inadequate stent expansion, stent fracture, and stent
foreshortening and malapposition. The purpose of this paper
is to reduce the incidence of ST and ISR of SE architectures,
more from the mechanical structural and procedural aspects
than the biological material aspect. However, the design factors
of stents often influence the biological and even clinical
outcomes. The importance of between stenting architectures
and biological safety in the process of coronary artery disease
has been shown in the study. The X-PLSM, in conjecture
with numerical homogenization method, is used to establish
a heuristic multiscale topology optimization approach for
seeking novel auxetic stenting structural architecture. The main
drawbacks of most current SE stents are expected to be avoided.
The numerical examples and simulations show that the
topologically optimized structures offer auxetic deformation that
can enable the stenting structures automatically and adaptively to
deform (e.g., expansion). The unusual deformation mechanism
will help overcome the inadequate stent expansion, stent fracture
and stent malapposition particularly in self-expanding stents. The
auxetic structures can also miniaturize the catheter enclosing
the stent, which increases the deliverability of the stent system
during the PCI procedure and avoids the immediate injure
of the vessel. The stenting structures can also supply variable
hoop strengths that will adapt to different radial forces when
the artery cross-sectional shapes subject to change. When the
shape getting smaller larger hooping strength, and vice versa,
due to the enhanced indentation performance. The auxetic
structures will also have a better capability to absorb vibration
energy. In this work, topologically optimized architectures with
auxetic metamaterials has been demonstrated to be able to
overcome the drawbacks of self-expanding (SE) stents. Moreover,
the proposed design optimization methodology and the auxetic
cellular composite structures can also be extended to other
biomedicine implants, such as esophageal stents, biliary stents,
and femoropopliteal artery stents. It is noted that the blood
flow also plays an important role in stent design performance.
However, this manuscript mainly provides an opportunity
to investigate how the unique mechanical properties gained
from the optimized auxetic structure will benefit and help
resolve inadequate stent expansion, stent fracture and stent
malapposition in self-expanding stents. Hence, topologically
optimized stents under the fluid dynamic consideration is outside
the scope of this work, yet future studies expanding on the gained
knowledge may reveal interesting further insights.
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